ClydeEMarkowitzMD
Neurology • Philadelphia, PANeuroimmunology/Multiple Sclerosis
Associate Professor of Neurology, University Pennsylvania
Dr. Markowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# 2
Philadelphia, PA 19104Phone+1 215-662-3606
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1991 - 1994- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1990 - 1991
Columbia University Vagelos College of Physicians and SurgeonsClass of 1990
Certifications & Licensure
PA State Medical License 1998 - 2024
NY State Medical License 1992 - 2001- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis Start of enrollment: 2007 Jun 01
- Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 139 citationsMacular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple SclerosisBryn M. Burkholder, Benjamin Osborne, Michael J. Loguidice, Esther R. Bisker, Teresa C. Frohman
Archives of Neurology. 2009-11-09 - 475 citationsRelation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple SclerosisJennifer B. Fisher, Dina A. Jacobs, Clyde E. Markowitz, Steven L. Galetta, Nicholas J. Volpe
Ophthalmology. 2006-02-01 - 304 citationsGlatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trialJerry S. Wolinsky, Ponnada A. Narayana, Paul O'Connor, P. K. Coyle, Corey C. Ford
Annals of Neurology. 2007-01-01
Press Mentions
New Drug, TASCENSO ODT® (Fingolimod), Launched to Meet the Needs of Multiple Sclerosis Patients in the US Left Without Essential Patient SupportFebruary 13th, 2023- Four People in the World Have a Mysterious Dementia. Could It Hold a Key to Alzheimer's?July 11th, 2021
New MS Drug Approved by FDAMarch 29th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
